Not too late to buy Disney shares, says wealth manager
Disney+ will hit its 50 million subscriber goal quickly, says Ross Gerber of Gerber Kawasaki who considers Disney shares a strong buy. The streaming service signed up more than 10 million users on its debut Tuesday......»»

Disney shares have more upside, "even after today"s phenomenal run," Jim Cramer says
"Not long ago, Iger told me 'we're just getting started,' and I say 'it's still not too late to join him on his ride of a lifetime,'" the "Mad Money" host says......»»
Australia"s AMP at risk of hemorrhaging wealth clients: Macquarie
SYDNEY (Reuters) - AMP Ltd could see A$35 billion in investor outflows due to the hit to its reputation from board-level misconduct, analysts at Macquarie Group Ltd said on Friday, sending shares in the Australian wealth manager to a seven-year low......»»
Long-term investing in equity is the surest way to healthy wealth creation
A fund manager shares what he learnt from Warren Buffett, after attending Berkshire Hathaway's AGMs over the years.....»»
A Disney World employee shares what it"s really like to work inside Cinderella"s Castle
Courtesy of Disney. The magic of Disney wouldn't be the same without the cast members who make it all possible, including the manager of Cinderella's Royal Table, Debbi Sacleux. Cinderella's Royal Table is a dining experience located inside Cinderell.....»»
Why You Should Buy Disney Stock As It Nears Five-Year Highs
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Disney shares have been more or less moving sideways since late 201.....»»
Disney Logs a Sleepy Start to What Will Be a Very Busy 2019
It’s still not too late to scoop up shares ahead of Mickey Mania......»»
Will This FDA Decision Set Off These Late-Stage Dermatitis Studies?
Dermira shares jumped on Tuesday after the firm announced that the FDA has granted Fast Track designation for lebrikizumab, its treatment moderate-to-severe atopic dermatitis......»»
NewsWatch: This wealth manager picked a home-run stock in 2019. Here’s what he likes for 2020
Our call of the day from wealth manager Ross Gerber takes a look at a home-run stock-pick in 2019 and some possibilities for the coming year......»»
Ulta Beauty Q3 Earnings Make a Big Impression
Ulta Beauty shares popped after it released better than expected fiscal third-quarter financial results late Thursday......»»
How DocuSign Did It Again With Q3 Earnings
DocuSign shares rose after it released better than expected fiscal third-quarter financial results late on Thursday......»»
Omeros Aces Late-Stage Trial Of Transplant Drug Narsoplimab
Shares of thinly-traded small-cap biopharma Omeros Corporation (NASDAQ: OMER) are advancing Wednesday following a positive readout from a pivotal Phase 3 study of its investigational asset 0.....»»
Need to Know: This wealth manager picked a home-run stock in 2019. Here’s what he likes for 2020
Our call of the day from wealth manager Ross Gerber takes a look at a home-run stock-pick in 2019 and some possibilities for the coming year......»»
Disney"s Stock Hits Its New All-Time High As Roku Even Benefits From Disney+ Momentum
Shares of Walt Disney Co (NYSE: DIS) were in breakout mode after reports surfaced about momentum in its Disney+ program. According to Apptopia, the momentum is nearing to 1 mill.....»»
Disney"s Stock Hits Its New All-Time High As Roku Even Benefits From Disney+ Momentum
Shares of Walt Disney Co (NYSE: DIS) were in breakout mode after reports surfa.....»»
Global shares tick up as hopes for Sino-U.S. breakthrough stay intact
Global shares ticked up on Monday and oil rebounded after a big fall late last week, as investors clung to hopes Beijing and Washington could reach a compromise in trade talks although increasing tensions over Hong Kong unsettled market confidence......»»
Saudi Aramco IPO gets $44.3 billion in bids so far: lead manager
Saudi Aramco has received bids for its shares totaling $44.3 billion so far, lead manager Samba Capital said on Friday, putting its initial public offering on track to be over-subscribed......»»
The Ratings Game: Drug maker ChemoCentryx shares rocket on blockbuster potential in rare autoimmune disease
A set of conclusive findings from a late-stage clinical trial testing ChemoCentryx Inc.’s experimental vasculitis treatment surprised company executives and investors, who now say they are bullish on the sales and pipeline potential of avacopan......»»
Orion Engineered Senior Manager buys 2,500 additional shares
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
What This Study For ANCA Vasculitis Means Going Forward
ChemoCentryx shares more than tripled on Tuesday after the firm, in conjunction with Vifor Fresenius Medical Care Renal Pharma, announced positive topline data from its late-stage trial of avacopan........»»
Wall Street hits new record high on Disney, Best Buy
Wall Street's three main indexes hit all-time highs on Tuesday, as gains for Disney and Best Buy countered weak consumer confidence data and a slump in shares of discount store operator Dollar Tree......»»